According to Medistim's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.90. At the end of 2025 the company had a P/S ratio of 5.30.
Year | P/S ratio | Change |
---|---|---|
2025 | 5.30 | 9.89% |
2024 | 4.82 | -37.27% |
2023 | 7.68 | -11.29% |
2022 | 8.66 | -45.19% |
2021 | 15.8 | 11.44% |
2020 | 14.2 | 46.01% |
2019 | 9.71 | 156.99% |
2018 | 3.78 | -15.02% |
2017 | 4.45 | -8.91% |
2016 | 4.88 | 32.06% |
2015 | 3.70 | 81.15% |
2014 | 2.04 | -5.64% |
2013 | 2.16 | 5.98% |
2012 | 2.04 | -6.39% |
2011 | 2.18 | -27.26% |
2010 | 3.00 |